top of page
News
Chat
Insights
Portfolios
Education
About
Pricing
BPIQ API
BPIQ APEX
ESPR Inks Another Ex-US Commercialization Deal
ESPR announced another major ex-US commercialization deal yesterday for its LDL-C lowering drugs, for certain ex-US countries. The deal...
Apr 26, 2021
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
